Mild Course of SARS-CoV-2 Infection in a Liver Transplant Recipient Undergoing Plasma Exchange and Defibrotide for Acute Graft Rejection

Transplantation. 2021 Feb 1;105(2):e22-e24. doi: 10.1097/TP.0000000000003592.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • COVID-19 / therapy*
  • COVID-19 / virology
  • Female
  • Graft Rejection / drug therapy*
  • Humans
  • Liver Transplantation*
  • Middle Aged
  • Plasma Exchange*
  • Polydeoxyribonucleotides / therapeutic use*
  • SARS-CoV-2*
  • Viral Load

Substances

  • Polydeoxyribonucleotides
  • defibrotide